ER and PR expression are also tightly correlated with the first of two classic histologic subtypes of endometrial cancer, type I and type II [8], which are used in combination with clinical features to risk-stratify patients and tailor treatment regimens. This evidence concerns the gene ESR1 and endometrial cancer.